Dr. Carpentier shares his experience with and looks into the science behind the use of dexamphetamine treatment as a novel off-label treatment for a number of female chronic disorders that do not respond well to conventional therapy including recurrent pregnancy loss, inflammation, and ongoing pain.    The primary article of focus for this journal club, "The neurotransmitter dopamine modulates vascular permeability in the endothelium", along with a list of references can be downloaded to accompany the webinar.

This content is only available to current IIRRM Members.  Please Log in below or click here to become a member.   Time to renew your membership? - Log in below and visit your account page.